Published date: 11 May 2021
Last edited date: 19 October 2021
This notice was replaced on 21 October 2021
This notice does not contain the most up-to-date information about this procurement. The most recent notice is:
Future opportunity (published 21 October 2021)
Closed future opportunity - This means that a potential contract has passed its approach to market date. A buyer can choose to consider any supplier interest or convert this notice into an opportunity ready for live procurement.
Contract summary
Industry
Pharmaceutical products - 33600000
Pharmacy services - 85149000
Location of contract
North East, North West, Yorkshire and the Humber, Isle of Man
Value of contract
£36,500,000
Procurement reference
CM/PHS/21/5460
Published date
11 May 2021
Approach to market date
8 December 2021
Contract start date
1 April 2022
Contract end date
31 March 2023
Procedure type
Open procedure (above threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies - North of England
More information
Spend profile
Financial year | Budget |
---|---|
2022/2023 | £36,500,000 |
About the buyer
Contact name
Tony Concepcion
Address
Commercial Medicines Unit - NHS England
2nd Floor Rutland House
Runcorn
WA7 2ES
England
Share this notice